Tech Company Financing Transactions
Sequella Funding Round
On 2/22/2010, Sequella received $2 million in investment from private investors.
Transaction Overview
Company Name
Announced On
2/22/2010
Transaction Type
Debt
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9610 Medical Center Dr. 200
Rockville, MD 20850
USA
Rockville, MD 20850
USA
Phone
Website
Email Address
Overview
Sequella develops products to improve diagnosis and treatment of infectious diseases that pose serious risk to public health and have both significant market opportunities and clear commercialization pathways.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carol Nacy
Chief Scientific Officer
Leo Einck
Browse more venture capital transactions:
Prev: 2/22/2010: IntelliOne Technology venture capital transaction
Next: 2/22/2010: Pulmonx venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs